Nortriptyline and Ethynodiol: Interaction Details
- Nortriptyline
- AventylPamelor
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Nortriptyline and Ethynodiol interaction:
Nortriptyline
- Aventyl
- Pamelor
Ethynodiol
We don't have a drug information page for Ethynodiol yet. Have a question about Ethynodiol? Ask a pharmacist, free →
What Happens When You Take Nortriptyline With Ethynodiol
What can happen when they are taken together (rated Moderate)
Attenuation of antidepressant effectiveness; toxicity (drowsiness, , akathisia)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Estrogens can, in isolated cases, either enhance or diminish the pharmacologic effects of tricyclic antidepressants.3 In some instances the antidepressant effect is lost while signs of tricyclic antidepressant toxicity appear at the same time.1
The interaction seems to depend on the estrogen dose.2 It may matter clinically mainly for patients who were already stabilized on a tricyclic antidepressant and then begin estrogen therapy.6
The Nortriptyline and Ethynodiol Interaction, Explained
Nortriptyline is an antidepressant, and ethynodiol is an estrogen-type hormone found in some birth control pills. In rare cases, the hormone may change how your body handles nortriptyline. This could make it work less well, or cause too much of it to build up, and sometimes both can happen together. Signs of too much include drowsiness, dizziness or light-headedness from low blood pressure, and restlessness. This is based on theory and isolated reports, and it seems more likely with higher estrogen doses or when a hormone is started after your antidepressant is already working well.
Don't change anything on your own. If your mood slips or you feel unusually sleepy or restless, tell your pharmacist or doctor. Your care team can adjust doses and keep a closer eye on you.
Mechanism (theoretical): estrogens may induce of the TCA or inhibit hepatic microsomal enzymes. Nortriptyline is not a , so reduced exposure would mean less antidepressant effect, while reduced would mean accumulation and toxicity.
- Effect: variable and paradoxical, with loss of antidepressant and TCA toxicity (, , akathisia) possible, even concurrently.
- Onset: delayed. Appears estrogen dose-related. Most relevant when estrogen is started in patients stabilized on a TCA.
- Evidence: theoretical, isolated cases. Severity: moderate.
- Management: monitor clinical response and adverse effects after estrogen initiation. Consider TCA . Downward dose adjustment of either agent may restore efficacy or resolve toxicity. Withdrawal of a drug may be required.
See the 9 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Nortriptyline and Ethynodiol Interact
The likely mechanism
Possible estrogen-enhanced of the or estrogen of hepatic microsomal enzymes
How to Manage the Nortriptyline and Ethynodiol Interaction
Your care team can usually manage this by watching how you respond and tailoring doses.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist or doctor if either medicine is started or changed, especially a new hormone while you are stable on nortriptyline.
- Report mood changes, drowsiness, dizziness on standing, or restlessness.
- If problems appear, the dose of either medicine may need to be adjusted and individualized by your care team. In some cases, one of the medicines may need to be stopped, but only under their guidance.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Nortriptyline or Ethynodiol need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
7 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Estrogens may well affect response to antidepressants
A study examined the qualitative effects of giving estrogen together with (TCAs). In one trial, 30 depressed female prisoners were randomly allocated to 4 treatment groups.
Ten patients received placebo, 10 received imipramine (150 milligrams/day) and placebo, 5 received imipramine (150 milligrams/day) with ethinyl estradiol (50 micrograms/day), and 5 received imipramine (150 milligrams/day) with ethinyl estradiol (25 micrograms/day). The 10 patients given placebo showed no improvement over the 6-week study.
The 10 patients taking estrogen with imipramine showed significantly greater symptom improvement than the 10 patients taking imipramine alone. At 2 weeks, however, the 5 patients receiving imipramine with high-dose estrogen had improved less than those receiving imipramine with low-dose estrogen.
The only side effect reported was drowsiness, which occurred only in patients taking imipramine. After ethinyl estradiol was stopped, the high-dose estrogen group needed 2 weeks to perform as well as the low-dose group, an effect attributed to residual estrogen in the high-dose group.
In another group, 5 women who received imipramine 150 milligrams and ethinyl estradiol 50 micrograms daily improved less than 10 patients receiving imipramine alone. The patients on the combination also had severe side effects, including lethargy, coarse tremor, and systolic .1
-
Report 2 · Study title
Estrogen-imipramine interaction (letter)
A case report described an interaction in a 32-year-old woman taking conjugated estrogens 2.5 milligrams and imipramine 100 milligrams. She developed lethargy, tremors, and signs of depersonalization.
After 2 years of therapy, she raised her estrogen dose to 5 milligrams and then to 7.5 milligrams daily. She then experienced nausea, constant headaches, and low normal blood pressure.
All laboratory results were normal. The side effects subsided when the estrogen was discontinued.2 Some investigators have suggested that the side effects arose from enhanced effects secondary to estrogen of microsomal enzymes.3
-
Report 3 · Study title
Drug interactions with clomipramine
A study assessed women who received either clomipramine with oral contraceptives or clomipramine alone. At the start, 30 women were taking the combination, but 12 later dropped out.
The 18 remaining patients on the combination were matched with 18 patients taking clomipramine alone. No significant difference was found in the patients' responses to clomipramine.
It was suggested that side effects did not differ significantly between the groups; however, matching took place after patients had dropped out of the study. Had patients been matched before the study, different conclusions might have been reached.4
-
Report 4 · Study title
Influences of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine
A study examined the effects of oral contraceptives on clomipramine in 42 women aged 18 to 40 years. Twenty-three women took clomipramine 25 milligrams at bedtime, and 19 took clomipramine 25 milligrams at bedtime together with oral contraceptives.
During the 4-week study, 3 patients in the control group (2 because of side effects) and 5 in the experimental group (2 because of side effects) dropped out. Venous blood samples were collected weekly to measure serum clomipramine concentrations. No difference in was seen between the groups, although this finding may be partly attributable to the low clomipramine dose used.5
-
Report 5 · Study title
Tricyclic-induced akathisia in patients taking conjugated estrogens
Three patients developed akathisia while receiving conjugated estrogens and at the same time. A 24-year-old patient taking clomipramine 120 milligrams/day for anorexia nervosa and conjugated estrogens 1.25 milligrams/day for amenorrhea developed restless legs and a constant urge to keep moving.
Estrogen was stopped and benztropine 2 milligrams was given, producing marked reduction and resolution within 48 hours. A 55-year-old patient on conjugated estrogens 1.25 milligrams/day who was prescribed amitriptyline 50 milligrams/day for depression developed akathisia and disorientation.
Within hours of starting amitriptyline, the patient was confused, restless, and had an inner urge to move continuously. Symptoms resolved after amitriptyline was discontinued.
A positive rechallenge occurred at one week with doxepin 100 milligrams, with resolution after doxepin was discontinued. A third case of akathisia was reported in a 35-year-old patient receiving conjugated estrogens 1.25 milligrams/day and amitriptyline 50 milligrams/day. Akathisia appeared within a few hours of the first amitriptyline dose and resolved within 48 hours of stopping the antidepressant.6
-
Report 6 · Study title
Imipramine disposition in users of oral contraceptive steroids
In women receiving low-dose oral contraceptives (50 micrograms or less of ethinyl estradiol), the absolute of imipramine rose from 27% to 44% (p less than 0.05), as shown by an increase in the .7
-
Report 7 · Study title
Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing
Estrogens may inhibit the oxidation of (TCAs) through effects on microsomal enzymes.8 Many TCAs are by oxidation and conjugation pathways.
Inhibited TCA oxidation could lead to accumulation and toxicity because of reduced . Estrogens are also suspected of having other central nervous system effects that produce an antidepressant action.9
Nortriptyline and Ethynodiol: Common Questions
How serious is the Nortriptyline and Ethynodiol interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Nortriptyline and Ethynodiol interaction managed?
Your care team can usually manage this by watching how you respond and tailoring doses. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or doctor if either medicine is started or changed, especially a new hormone while you are stable on nortriptyline. Report mood changes, drowsiness, dizziness on standing, or restlessness. If problems appea… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Nortriptyline and Ethynodiol Interaction
Ask in your own words about taking Nortriptyline and Ethynodiol together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (9)
- Prange AJ Jr: Estrogens may well affect response to antidepressants. JAMA 1972; 219:143-144.
- Khurana RC: Estrogen-imipramine interaction (letter). JAMA 1972; 222:702-703. PubMed
- Somani SM & Khurana RC: Mechanism of estrogen-imipramine interaction (letter). JAMA 1973; 223:560. DOI
- Beaumont G: Drug interactions with clomipramine. J Int Med Res 1973; 1:480-484.
- Luscombe DK & John V: Influences of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine. Postgrad Med J 1980; 56(suppl 1):99-102.
- Krishnan KR, France RD, & Ellinwood EH: Tricyclic-induced akathisia in patients taking conjugated estrogens. Am J Psychiatry 1984; 141:696-697. PubMed
- Abernethy DR, Greenblatt DJ, & Shader RI: Imipramine disposition in users of oral contraceptive steroids. Clin Pharmacol Ther 1984; 35:792-797. DOI
- John VA, Luscombe DK, & Kemp H: Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing. J Int Med Res 1980; 8(suppl 3):88-95.
- Oppenheim G: Estrogens in the treatment of depression: neuropharmacological mechanisms. Biol Psychiatry 1983; 18:721-725.
Other Serious Interactions of Nortriptyline and Ethynodiol
Also serious with Nortriptyline
- Linezolid InjectionContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- DronedaroneContraindicated
Also serious with Ethynodiol
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Nortriptyline
- Activated CharcoalMajor
- HenbaneMajor
- LithiumMajor
- ScopoliaMajor
- Black PepperModerate
- GrapeModerate
- GinkgoModerate
- QuercetinModerate
- + 192 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.